No Data
No Data
No Data
No Data
No Data
JMP Securities Reiterates Market Outperform on Kura Oncology, Maintains $32 Price Target
JMP Securities analyst Reni Benjamin reiterates Kura Oncology (NASDAQ:KURA) with a Market Outperform and maintains $32 price target.
BenzingaMay 6 23:03
Analysts Are Bullish on These Healthcare Stocks: Relay Therapeutics (RLAY), Kura Oncology (KURA)
TipRanksMay 6 12:30
Earnings Call Summary | Kura Oncology(KURA.US) Q1 2024 Earnings Conference
The following is a summary of the Kura Oncology, Inc. (KURA) Q1 2024 Earnings Call Transcript:Financial Performance:Kura Oncology's research and development expenses for Q1 2024 were reported as $36.3
Futu NewsMay 5 06:24 · Conference Call
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Kura Oncology (KURA) and Amgen (AMGN)
TipRanksMay 3 23:34
Wedbush Reiterates Outperform on Kura Oncology, Maintains $37 Price Target
Wedbush analyst Robert Driscoll reiterates Kura Oncology with a Outperform and maintains $37 price target.
Analyst UpgradesMay 3 21:42
Scotiabank Keeps Their Hold Rating on Kura Oncology (KURA)
TipRanksMay 3 19:43
No Data
No Data